chevron_leftBack
As of 24 April 2025, Mangoceuticals, Inc. has a market cap of $12.75M USD, ranking #32068 globally and #4586 in the United States. It ranks #3212 in the Healthcare sector, and #152 in the Health Information Services industry.
Key Stats
Market Cap
$12.75MUSD
Enterprise Value
$12.9MUSD
Revenue (TTM)
$615.87KUSD
EBITDA (TTM)
-$7.51MUSD
Net Income (TTM)
-$9.58MUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Health Information Services
CEO
Jacob Cohen
open_in_new
Employees
3
Founded
2021
IPO
21 Mar 2023
Website
mangoceuticals.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -8.9% | -2.9% | -54% | -33% | -19% | -51% |
Upcoming Earnings
Earnings Date
Wed, May 14
Earnings Time
bedtime
After Close
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
MGRX
Mangoceuticals Inc
ISIN: US56270V2051
Shares Out.:
Shares Outstanding:
6.249M1
Shares Float:
3.034M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.04 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Mangoceuticals, Inc.
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
